ASB Consultores’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-25,700
Closed -$311K 154
2024
Q4
$311K Buy
25,700
+2,000
+8% +$26.2K 0.13% 140
2024
Q3
$348K Buy
23,700
+6,000
+34% +$83.6K 0.14% 123
2024
Q2
$255K Sell
17,700
-1,600
-8% -$25.6K 0.09% 161
2024
Q1
$314K Buy
19,300
+8,200
+74% +$128K 0.08% 203
2023
Q4
$165K Sell
11,100
-12,900
-54% -$146K 0.06% 111
2023
Q3
$270K Buy
+24,000
New +$279K 0.11% 97
2023
Q2
Sell
-41,500
Closed -$390K 188
2023
Q1
$390K Buy
41,500
+13,200
+47% +$156K 0.16% 109
2022
Q4
$346K Buy
+28,300
New +$353K 0.14% 108

Other funds holding ELAN

ASB Consultores's ELAN Position: Q1 2025 in Review

ASB Consultores sold out of Elanco Animal Health (ELAN) in Q1 2025, closing a stake of 25,700 shares — an estimated $311K sold.

ASB Consultores first reported a position in ELAN in Q4 2022 and held it in 8 quarters. The position peaked at $390K in Q1 2023. 365 funds tracked by Wall St. Rank hold ELAN as of Q1 2025.

  • ASB Consultores reported no remaining Elanco Animal Health position as of Q1 2025 after selling out during the quarter.
  • ASB Consultores sold 25,700 Elanco Animal Health shares in Q1 2025, an estimated $311K.
  • ASB Consultores first reported a position in Elanco Animal Health in Q4 2022 and held it in 8 quarters.
  • ASB Consultores's Elanco Animal Health position peaked at $390K in Q1 2023.
  • 365 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2025.

Based on ASB Consultores's 13F filing for Q1 2025, filed 13 May 2025.